Fireside Chat: Beyond GLP-1 – Where Will the Next GPCR Success Story Come From?
11:30 am - Thursday 4th March 2027
- Beyond metabolic disease, where do pharma see the greatest unmet need and commercial opportunity across the GPCR landscape?
- Does success in this space require replicating GLP-1’s model, or can differentiated mechanisms in entirely different indications define the field’s next major win?
- What is the industry actually looking for right now when evaluating a new GPCR program, and how does that differ from what got funded or partnered five years ago?
